CBD Reduced Heart Attack Damage by 66% in Rats | Research

The takeaway

Rats treated with CBD after an induced heart attack had 66% smaller infarcts and better preserved heart function than untreated rats, but the effect required a living system to work.

Read this if you're interested in CBD's potential effects beyond the brain, particularly in cardiovascular health.

66% reduction in heart attack damage with CBD treatment

What the researchers found

Researchers induced heart attacks in rats by temporarily blocking the left anterior descending coronary artery for 30 minutes, then treated them with CBD (5 mg/kg) or vehicle for 7 days.

CBD-treated rats showed significantly better preserved heart function, with shortening fraction declining from 48% to 39% compared to 44% to 32% in controls. Most strikingly, infarct size was reduced by 66% in CBD-treated animals, despite nearly identical areas of tissue at risk.

The protective effect was associated with reduced inflammation: CBD-treated hearts showed less myocardial inflammation and dramatically lower IL-6 levels (254 vs. 2,812 pg/ml). However, when the experiment was repeated in isolated hearts (removed from the body), no protective effect was observed, suggesting CBD's cardioprotection depends on systemic processes rather than direct effects on heart tissue.

Why it matters

CBD had no known cardiovascular applications before this study. The finding that it dramatically reduced heart attack damage in rats, apparently through anti-inflammatory mechanisms, opened a new area of CBD research and raised questions about its potential in cardiovascular medicine.

The numbers in context

Infarct size reduced by 66% with CBD. Heart function (shortening fraction): CBD group 48% to 39%, controls 44% to 32% (p<0.05). IL-6 levels: CBD 254 pg/ml vs. controls 2,812 pg/ml (p<0.01). CBD dose: 5 mg/kg daily for 7 days.

How the study worked

For in vivo studies, rats underwent 30-minute coronary artery ligation and received CBD (5 mg/kg intraperitoneally) or vehicle for 7 days. Heart function was assessed by echocardiography. Infarcts were examined morphometrically and histologically. In ex vivo studies, CBD was administered 24 and 1 hour before hearts were harvested for isolated heart experiments.

What this study cannot tell us

This was an animal study with a small sample size. The heart attacks were surgically induced, which differs from natural heart attacks in humans. The CBD dose and route of administration may not translate directly to human use. The ex vivo finding limits understanding of the mechanism.

How to read the evidence

This is an animal study with a single dose level and relatively small numbers. While the results were dramatic, they require replication and human studies before any clinical conclusions.

When this study was published

Published in 2007. CBD cardiovascular research has continued, with some human studies exploring blood pressure effects, but no clinical trials for heart attack treatment have been completed.

The bigger picture

This was an early study demonstrating that CBD's anti-inflammatory properties could have cardiovascular applications. The observation that CBD's protection required a living system (not working in isolated hearts) suggested the mechanism involves immune modulation or systemic signaling rather than direct cardiac effects.

Questions still open

What systemic mechanisms mediate CBD's cardioprotection? Would CBD be protective if administered before a heart attack (preventively) rather than after? Can these findings translate to human cardiovascular disease?

Common questions

Could CBD prevent heart attacks in humans?

This study is far too preliminary to make that claim. It showed CBD reduced damage after an induced heart attack in rats, not that it prevents heart attacks. Human clinical trials would be needed.

Why didn't CBD work in isolated hearts?

The most likely explanation is that CBD's cardioprotection works through the immune system or other body-wide processes (like reducing inflammation via IL-6) rather than by acting directly on heart muscle cells.

Read the original research

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

American journal of physiology. Heart and circulatory physiology, 293(6), H3602-7

View on PubMed ↗

Citation

Durst, Ronen; Danenberg, Haim; Gallily, Ruth; Mechoulam, Raphael; Meir, Keren; Grad, Etty; Beeri, Ronen; Pugatsch, Thea; Tarsish, Elizabet; Lotan, Chaim. (2007). Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.. American journal of physiology. Heart and circulatory physiology, 293(6), H3602-7.